BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33845155)

  • 1. The implication of ROCK 2 as a potential senotherapeutic target via the suppression of the harmful effects of the SASP: Do senescent cancer cells really engulf the other cells?
    Şimay Demir YD; Özdemir A; Sucularlı C; Benhür E; Ark M
    Cell Signal; 2021 Aug; 84():110007. PubMed ID: 33845155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
    Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
    Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of senescent cell secretomes to identify common and specific features of the different senescent phenotypes: a tool for developing new senotherapeutics.
    Oguma Y; Alessio N; Aprile D; Dezawa M; Peluso G; Di Bernardo G; Galderisi U
    Cell Commun Signal; 2023 Sep; 21(1):262. PubMed ID: 37770897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy.
    Liu H; Xu Q; Wufuer H; Li Z; Sun R; Jiang Z; Dou X; Fu Q; Campisi J; Sun Y
    Aging Cell; 2024 Jan; 23(1):e13921. PubMed ID: 37475161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
    Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
    FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
    Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
    Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Samakkarnthai P; Saul D; Zhang L; Aversa Z; Doolittle ML; Sfeir JG; Kaur J; Atkinson EJ; Edwards JR; Russell GG; Pignolo RJ; Kirkland JL; Tchkonia T; Niedernhofer LJ; Monroe DG; Lebrasseur NK; Farr JN; Robbins PD; Khosla S
    Aging (Albany NY); 2023 May; 15(9):3331-3355. PubMed ID: 37154858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senescent Cells: A Therapeutic Target in Cardiovascular Diseases.
    Suda M; Paul KH; Minamino T; Miller JD; Lerman A; Ellison-Hughes GM; Tchkonia T; Kirkland JL
    Cells; 2023 May; 12(9):. PubMed ID: 37174697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria-targeted senotherapeutic interventions.
    Atayik MC; Çakatay U
    Biogerontology; 2022 Aug; 23(4):401-423. PubMed ID: 35781579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the role of senescence inducers and senotherapeutics as targets for anticancer natural products.
    Mamun AA; Sufian MA; Uddin MS; Sumsuzzman DM; Jeandet P; Islam MS; Zhang HJ; Kong AN; Sarwar MS
    Eur J Pharmacol; 2022 Aug; 928():174991. PubMed ID: 35513016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
    Malaquin N; Tu V; Rodier F
    Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senotherapeutics in Cancer and HIV.
    Sánchez-Díaz L; Espinosa-Sánchez A; Blanco JR; Carnero A
    Cells; 2022 Apr; 11(7):. PubMed ID: 35406785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel senomorphic agent, avenanthramide C, via the suppression of the senescence-associated secretory phenotype.
    Lim JS; Lee DY; Kim HS; Park SC; Park JT; Kim HS; Oh WK; Cho KA
    Mech Ageing Dev; 2020 Dec; 192():111355. PubMed ID: 32941937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senotherapeutic-like effect of Silybum marianum flower extract revealed on human skin cells.
    Woo J; Shin S; Cho E; Ryu D; Garandeau D; Chajra H; Fréchet M; Park D; Jung E
    PLoS One; 2021; 16(12):e0260545. PubMed ID: 34914725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The connection between the cardiac glycoside-induced senescent cell morphology and Rho/Rho kinase pathway.
    Şimay YD; Özdemir A; İbişoğlu B; Ark M
    Cytoskeleton (Hoboken); 2018 Nov; 75(11):461-471. PubMed ID: 30369081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Differential Effect of Senolytics on SASP Cytokine Secretion and Regulation of EMT by CAFs.
    Bogdanova DA; Kolosova ED; Pukhalskaia TV; Levchuk KA; Demidov ON; Belotserkovskaya EV
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular senescence in bone.
    Farr JN; Khosla S
    Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senescent Secretome of Blind Mole Rat
    Odeh A; Eddini H; Shawasha L; Chaban A; Avivi A; Shams I; Manov I
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senotherapeutics: Targeting senescent cells for the main age-related diseases.
    Boccardi V; Mecocci P
    Mech Ageing Dev; 2021 Jul; 197():111526. PubMed ID: 34166689
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Woo J; Shin S; Ji H; Ryu D; Cho E; Kim Y; Kim J; Park D; Jung E
    Nutrients; 2022 May; 14(9):. PubMed ID: 35565945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.